Global Opioid Receptor Agonist Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Opioid Receptor Agonist Market Research Report 2024
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
According to Mr Accuracy reports’s new survey, global Opioid Receptor Agonist market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Opioid Receptor Agonist market research.
Key manufacturers engaged in the Opioid Receptor Agonist industry include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Opioid Receptor Agonist were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Opioid Receptor Agonist market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioid Receptor Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior
Segment by Type
Fentanyl
Codeine
Morphine
Others
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Opioid Receptor Agonist report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Opioid Receptor Agonist market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Opioid Receptor Agonist market research.
Key manufacturers engaged in the Opioid Receptor Agonist industry include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Opioid Receptor Agonist were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Opioid Receptor Agonist market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioid Receptor Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior
Segment by Type
Fentanyl
Codeine
Morphine
Others
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Opioid Receptor Agonist report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices